The following is a compendium of articles and op-eds I have written since 2013. It is an updated version of "Analyzing The Opioid Crisis: 65 Articles By Dr. Josh Bloom," which was published in 2019.
Dr. Jeff Singer of the Cato Institute, and also a member of the ACSH Board of Scientific Advisors was invited to participate in a panel discussion on ending the opioid crisis. Here is a description of the event and a link to a YouTube video of the discussion.
Dr. Bloom has written eloquently and often about individuals with chronic pain, caught-up in opioid guidelines designed to reduce the deaths due to drug overdoses. But many, if not most of those deaths, are due to despair. Wouldn’t it be better to treat this problem and ease the guidelines on individuals in chronic pain that are “collateral damage?”
While it remains popular to attribute the opioid‐related overdose crisis to doctors prescribing pain relievers to patients, the evidence shows there is no correlation between prescription volume and non‐medical opioid use or opioid use disorder.
The answer to that question: They both purport to improve health outcomes by harnessing the state’s regulatory authority for taxation or prescribing behavior. However, neither has shown to produce any health benefit. A new study shows that Florida physicians follow the rules, but not whether the rules help patients.
From JAMA Pediatrics to Yahoo Finance, our work continues to be cited and published all over the world. Check out where we recently appeared.
The enormous Rand Corporation just issued a 265-page report discussing how and why fentanyl is plaguing the United States. Interesting stuff, but "itsy bitsy" ACSH was all over this years ago. See for yourself.
Fentanyl washed upon our shores several decades ago, as China White. Today, the fentanyl market has more of a Breaking Bad vibe. A thorough study by the Rand Corporation suggests that fentanyl is a whole quantum different from the opioid crisis narrative.
Proposed guidelines for physicians from the U.S. Preventative Services Task Force recommend screening everyone over the age of 18 for drug use. Mind you, that's without having evidence of benefit or harm. Can the reasoning "it can't hurt" be an acceptable justification for the move?
Dr. Jeffrey Singer (pictured) is one of the brave physicians on the front line in the battle against anti-opioid madness. He graciously gave us permission to reprint his recent Cato Institute blog post. It speaks directly to the role of government in determining who gets what pain medicine, and how much. Dr. Singer addresses just this as he explains why Sen. Robert Portman (R-OH) went way off the deep end, proposing a national three-day limit on opioid prescriptions following surgery -- evidence be damned.
Opioid hysteria is not confined to the U.S. or Canada. A British group writing for the BBC manages to get all the usual stuff -- and then some -- wrong. So here's a deal: We keep baseball, they keep cricket, and we both stop writing idiotic, misleading papers on the phony "opioid crisis." Jolly good idea if you ask us!
The CDC just released "Provisional Drug Overdose Death Counts," which seems to imply that opioid overdose deaths are falling for the first time. Some will doubtlessly take credit for ending the opioid crisis. But they shouldn't.